Entrepreneurship is a necessary talent for turning a promising idea into a commercial innovation that helps people. These webinars and resources support organizing and growing companies to produce the next wave of biotechnology innovations.
Get ready to take your business development strategy from the boardroom to the beach at the BIO Investment & Growth Summit, happening March 2–3, 2026, in sunny Miami Beach!
Before you pack your sunglasses, join this lively walkthrough of the BIO Partnering™ system—your essential tool for connecting with investors, innovators, and dealmakers who can take your company to the next level.
In this session, you’ll learn how to:
- Craft a standout partnering profile that catches attention
- Search for and identify high-value partners and investors
- Send targeted meeting requests that lead to real opportunities
- Manage your schedule so you can focus on making deals and maybe catch a few rays)
- Don’t miss this chance to ride the wave of opportunity and arrive in Miami ready to make the most of every meeting.
In September 2025, the U.S. FDA launched a major enforcement campaign targeting direct-to-consumer (DTC) pharmaceutical advertising that misleads patients or downplays risks. Following a September 2025 presidential directive, the agency announced hundreds of enforcement actions—including over 100 cease-and-desist letters—signaling a zero-tolerance stance toward unbalanced or deceptive ads. While most of the letters focused on DTC content, FDA also sent letters for health care provider (HCP) promotion. The message: Government scrutiny and enforcement will significantly increase for biopharma as well as medical device promotion. This webinar includes regulatory compliance and drug advertising compliance experts who dissect the FDA’s mindset and ways to proactively mitigate concerns.
In this webinar, panelists:
– Drill down into FDA’s renewed enforcement areas
– Dissect the implications of increased enforcement on the industry
– Identify specific cases that are clear examples for company concern
– Isolate the key principles for avoiding violations and demonstrating good faith
Rising service agreement costs and shrinking support from original equipment manufacturers (OEMs) have created a growing challenge for life science organizations. Many labs are stuck juggling multiple contracts, vendors, and renewal cycles — losing both time and money along the way.
This webinar explores an alternative approach: centralizing lab equipment service events under one provider. You’ll hear from experts at SU Group, a company with decades of actuarial data on lab equipment performance, and from Joe Dragavon, Director Core Facilities and Shared Instrumentation & Research and Innovation Office Director, Advanced Light Microscopy Core BioFrontiers Institute, who successfully implemented this model and realized both cost savings and efficiency gains.
Attendees will walk away with:
- A clear understanding of the challenges with today’s service agreement landscape
- An introduction to a centralized, data-driven model for managing equipment service
- A real-world example of how this model works in practice and the benefits achieved
- Practical considerations for evaluating whether this approach is right for your organization
Wrap up the week with an executive overview of BIO Business Solutions and a deep dive with our flagship partner, Avantor. Learn how the program delivers ongoing value and discover exclusive offers and procurement strategies available to BIO members.
Agenda Overview:
- BIO Business Solutions Overview by BIO Vice President of Business Development, Jeff Vallerga
- Avantor – Learn how to drive purchasing efficiency and lab performance with one of the life science industry's leading suppliers. From everyday consumables to capital equipment, discover how member companies leverage Avantor’s flagship program for exclusive pricing, custom sourcing support, and supply chain optimization.
- Q&A
- Closing Remarks & Next Steps
BIO Business Solutions® is the largest cost-savings program for the life sciences industry, leveraging the collective buying power of thousands of member companies to deliver exclusive pricing on lab supplies, insurance, office essentials, and more, all at no additional cost to members.
Optimize day-to-day operations with cost-saving insights from leaders in office supplies, logistics, and travel. Hear from ODP and Corporate Traveler on how to stretch your budget while supporting your team’s productivity and mobility.
Agenda Overview:
- BIO VP of Business Development, Jeff Vallerga kicks off the session with practical ways BIO members can unlock value and savings through BIO Business Solutions.
- ODP Business Solutions – Explore recently enhanced savings on everyday office and facility supplies, plus flexible procurement options that fit the way your team works.
- Corporate Traveler – Learn how to simplify travel planning and reduce costs with personalized travel management services built for biotech teams.
- UPS Healthcare – Discover streamlined shipping and logistics solutions tailored for life sciences—from regular and small package shipping to cold chain support and customs expertise.
- Live Q&A
- Closing Remarks
BIO Business Solutions® is the largest cost-savings program for the life sciences industry, leveraging the collective buying power of thousands of member companies to deliver exclusive pricing on lab supplies, insurance, office essentials, and more, all at no additional cost to members.
From secure data sharing to executive expertise and workflow automation, this session highlights the digital and strategic tools that help life science companies scale efficiently. Presentations from ShareVault, PSC Software, and BiotechExec will showcase real-world use cases and member-driven results.
Agenda Overview:
- BIO Business Solutions Overview – unlocking value and savings
- ShareVault – Learn how secure document sharing can accelerate due diligence, streamline fundraising, and safeguard your most critical files.
- PSC Software – Discover how intuitive, scalable platforms like ACE Starter support end-to-end audit workflows, reduce risk, and boost productivity.
- BiotechExec – See how executive-level, fractional leadership can fill critical talent gaps and provide strategic direction for growing companies.
- Live Q&A
- Closing Remarks
BIO Business Solutions® is the largest cost-savings program for the life sciences industry, leveraging the collective buying power of thousands of member companies to deliver exclusive pricing on lab supplies, insurance, office essentials, and more, all at no additional cost to members.
Explore financial and HR services that empower life science companies to grow with confidence. Hear from Brex, Aon Risk, and ADP R&D Tax Credit on how to simplify expense management, access turnkey HR support, and capitalize on valuable tax credits.
Agenda Overview:
- BIO Business Solutions Overview - unlocking value and savings.
- Brex – Discover how to streamline company spending and optimize your financial runway with powerful, founder-friendly tools.
- ADP Tax Credits – See how your company’s activities may qualify for valuable federal R&D tax credits and how ADP can help you claim them.
- Aon Risk Insurance – Learn how to manage risk across the life sciences enterprise, from directors & officers (D&O) insurance to data privacy, cyber liability, and clinical trial protection.
- Live Q&A
- Closing Remarks
BIO Business Solutions® is the largest cost-savings program for the life sciences industry, leveraging the collective buying power of thousands of member companies to deliver exclusive pricing on lab supplies, insurance, office essentials, and more, all at no additional cost to members.
Explore lab optimization strategies, streamlined contract consolidation, and how to connect with the right experts for regulatory submissions and audit readiness. Hear from American Laboratory Trading (ALT), SU Group, and PSC Biotech as they present cost-effective approaches to enhancing lab operations and ensuring compliance at every growth stage.
Agenda Overview:
- BIO VP of Business Development kicks off the session with practical ways members can unlock value and savings through BIO Business Solutions.
- American Laboratory Trading (ALT) – Discover the benefits of sourcing refurbished lab equipment to lower capital costs while maintaining quality and performance.
- SU Group LLC – Learn how to consolidate equipment service contracts for greater efficiency, cost control, and vendor management.
- PSC Biotech – Get insights into tailored consulting support for regulatory planning, audit readiness, and quality systems implementation.
- Live Q&A
- Closing Remarks
BIO Business Solutions® is the largest cost-savings program for the life sciences industry, leveraging the collective buying power of thousands of member companies to deliver exclusive pricing on lab supplies, insurance, office essentials, and more, all at no additional cost to members.
Join Thermo Fisher Scientific for an exclusive webinar introducing a transformative approach to biologics development and clinical scale-up. Their "Path to IND for Biologics" method accelerates the journey from DNA to IND/IMPD submission and first-in-human clinical trials in as few as 9 months. Dr. Elena Gontarz, a leading expert in the biologics industry, will guide you through this innovative process, leveraging AI/ML, transposase technology, and integrated solutions during the session: "Path to IND for Biologics: From DNA to First-in-Human in 9 Months." Following the presentation, Dr. Gontarz will answer audience questions and discuss how these novel strategies can streamline the development of complex biologics, such as Fc-fusion proteins and bispecific antibodies, driving them swiftly from development to commercialization.
Get a sneak peek on this novel platform
Terms and Conditions: Titer levels provided are estimates based on third party results and may vary depending on molecule type or other factors. Timeline from DNA to drug product and start of clinical trials for all path to IND for biologics options may vary depending on molecule type or other factors and are estimates to be finalized after third party cell line development dates are available and confirmed. 9-month timeline will incur additional risk.
Learn more about Dr. Elena Gontarz's expertise and background: